SRS (Stereotactic Radiosurgery) Plus Ipilimumab
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)
- Status
- COMPLETED
- Phase
- PHASE3
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE4
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)
- Status
- COMPLETED
- Phase
- PHASE2